insights_auto
Why is CUV up 3,91%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,71
arrow_upward
+3,91%(+0,29) 1D
11 Nov., 12:11:48 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7,40
High
A$7,73
Low
A$7,40
Mkt. cap
389,26 m
Avg. vol.
154,28 k
Volume
28,32 k
Dividend
0,65%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,54
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
Open
A$7,40
High
A$7,73
Low
A$7,40
Mkt. cap
389,26 m
Avg. vol.
154,28 k
Volume
28,32 k
Dividend
0,65%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,54
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
News stories
From web sources and news partners
investingLive
·
2 uur gelede
UBS keeps 8,900 S&P 500 target for end-2027, says 20% derating sets up strong gains
Investing.com
·
3 uur gelede
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.30%
The Motley Fool
·
3 uur gelede
Only 2 Novembers Since 1950 Have Started Worse for the S&P 500 Than This One. Here's What Followed the Other Weak Starts.
TOKENPOST
·
1 uur gelede
S&P 500 and Nasdaq Close Higher With Gains of 2.3% and 2.7%
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com